Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement: A Prospective Non-inferiority Trial
Sponsor: Irrimaxcorp
Listed as NCT06489431, this PHASE3 trial focuses on Erectile Dysfunction and Penile Prosthesis; Complications, Infection or Inflammation and remains ongoing. Sponsored by Irrimaxcorp, it has been updated 5 times since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE3
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting PHASE3
Status: Suspended → Active Not Recruiting
-
Mar 2025 — Jan 2026 [monthly]
Suspended PHASE3
Status: Recruiting → Suspended
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
First recorded
Dec 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Irrimaxcorp
- Rush University Medical Center
- Urological Surgeons of Northern California
For direct contact, visit the study record on ClinicalTrials.gov .